Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

v3.22.2
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 41 $ 55,564 $ 116,783,602 $ (802) $ (107,108,664) $ 9,729,741
Balance (in shares) at Dec. 31, 2020 4,138 5,556,394        
Stock-Based Compensation     479,837     479,837
Issuance of Common Stock from Warrants, Net   $ 104 49,897     50,001
Issuance of Common Stock from Warrants, Net (in shares)   10,417        
Issuance of Common Stock from Private Placement   $ 15,311 7,973,550     7,988,861
Shares Issued to Panoptes Stockholders at Acquisition   1,531,101        
Foreign Currency Translation Adjustment       (14,334)   (14,334)
Net Loss         (4,553,633) (4,553,633)
Balance at Jun. 30, 2021 $ 41 $ 70,979 125,286,886 (15,136) (111,662,297) 13,680,473
Balance (in shares) at Jun. 30, 2021 4,138 7,097,912        
Balance at Mar. 31, 2021 $ 41 $ 70,979 125,023,994 9,671 (109,119,282) 15,985,403
Balance (in shares) at Mar. 31, 2021 4,138 7,097,912        
Stock-Based Compensation     262,892     262,892
Foreign Currency Translation Adjustment       (24,807)   (24,807)
Net Loss         (2,543,015) (2,543,015)
Balance at Jun. 30, 2021 $ 41 $ 70,979 125,286,886 (15,136) (111,662,297) 13,680,473
Balance (in shares) at Jun. 30, 2021 4,138 7,097,912        
Balance at Dec. 31, 2021   $ 126,640 135,418,188 (86,431) (120,879,349) 14,579,048
Balance (in shares) at Dec. 31, 2021 7 12,663,965        
Stock-Based Compensation     287,175     287,175
Issuance of Common Stock from Panoptes Holdback Shares   $ 4,035 (4,035)      
Issuance of Common Stock from Panoptes Holdback Shares (in shares)   403,461        
Foreign Currency Translation Adjustment       (138,430)   (138,430)
Net Loss         (5,965,825) (5,965,825)
Balance at Jun. 30, 2022   $ 130,675 135,701,328 (224,861) (126,845,174) 8,761,968
Balance (in shares) at Jun. 30, 2022 7 13,067,426        
Balance at Mar. 31, 2022   $ 126,640 135,634,109 (58,592) (124,444,363) 11,257,794
Balance (in shares) at Mar. 31, 2022 7 12,663,965        
Stock-Based Compensation     71,254     71,254
Issuance of Common Stock from Panoptes Holdback Shares   $ 4,035 (4,035)      
Issuance of Common Stock from Panoptes Holdback Shares (in shares)   403,461        
Foreign Currency Translation Adjustment       (166,269)   (166,269)
Net Loss         (2,400,811) (2,400,811)
Balance at Jun. 30, 2022   $ 130,675 $ 135,701,328 $ (224,861) $ (126,845,174) $ 8,761,968
Balance (in shares) at Jun. 30, 2022 7 13,067,426